Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Tenax Therapeutics, Inc. TENX

Full chart Compare
Set alert

Price alert · TENX

All alert types
1.63 USD -0.18 (-9.94%)

At closeNov 5, 2026, 4:00 PM EST

1.60 -0.03 -1.84%

After hours · Nov 5, 4:00 PM ET

1.57 Day range 1.77
1.31 52-week range 19.40
YTD
-86.63%
1 year
-77.01%

Financial health

Altman Z-Score

-1.85 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C-1 / 5 overall

  • DCF 4
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -9.1×
FY 2016: -99.9×FY 2017: -1.6×FY 2018: -0.3×FY 2019: -84.8×FY 2020: -1.4×FY 2021: -0.7×FY 2022: -0.3×FY 2023: -0.7×FY 2024: -5.4×FY 2025: -9.1×
FY 2016 5y median -0.7× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 4.9×
FY 2016: 3.2×FY 2017: 1.6×FY 2018: 0.2×FY 2019: 2.3×FY 2020: 3.0×FY 2021: 5.0×FY 2022: 2.2×FY 2023: 0.7×FY 2024: 1.0×FY 2025: 4.9×
FY 2016 5y median 2.2× FY 2025
P/FCF -13.4×
FY 2016: -3.5×FY 2017: -1.2×FY 2018: -0.3×FY 2019: -1.2×FY 2020: -1.5×FY 2021: -2.0×FY 2022: -0.3×FY 2023: -0.9×FY 2024: -6.4×FY 2025: -13.4×
FY 2016 5y median -2.0× FY 2025
EV/EBITDA -7.2×
FY 2016: -0.9×FY 2017: -1.4×FY 2018: 1.5×FY 2019: -0.5×FY 2020: -0.8×FY 2021: -0.5×FY 2022: -0.2×FY 2023: 0.5×FY 2024: 0.0×FY 2025: -7.2×
FY 2016 5y median -0.2× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -7.5%
FY 2016: -28.9%FY 2017: -84.7%FY 2018: -310.9%FY 2019: -86.5%FY 2020: -67.3%FY 2021: -50.8%FY 2022: -367.9%FY 2023: -108.2%FY 2024: -15.7%FY 2025: -7.5%
FY 2016 5y median -50.8% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -54.2%
FY 2016: -256.3%FY 2017: -99.5%FY 2018: -57.9%FY 2019: -222.5%FY 2020: -213.0%FY 2021: -765.1%FY 2022: -740.1%FY 2023: -95.2%FY 2024: -19.1%FY 2025: -54.2%
FY 2016 5y median -95.2% FY 2025
ROIC -58.1%
FY 2016: -260.0%FY 2017: -103.6%FY 2018: -58.6%FY 2019: -216.9%FY 2020: -200.1%FY 2021: -721.6%FY 2022: -480.4%FY 2023: -95.8%FY 2024: -21.2%FY 2025: -58.1%
FY 2016 5y median -95.8% FY 2025
ROA -50.5%
FY 2016: -188.2%FY 2017: -89.4%FY 2018: -51.1%FY 2019: -131.9%FY 2020: -143.4%FY 2021: -541.9%FY 2022: -324.5%FY 2023: -66.0%FY 2024: -18.2%FY 2025: -50.5%
FY 2016 5y median -66.0% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: -100.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -189.2%
FY 2016: -236.7%FY 2017: 82.5%FY 2018: 25.1%FY 2019: -24.1%FY 2020: -15.3%FY 2021: -231.7%FY 2022: 66.2%FY 2023: 25.5%FY 2024: -136.8%FY 2025: -189.2%
FY 2016 FY 2025
EPS (diluted) -16.5%
FY 2016: -211.5%FY 2017: -1504.0%FY 2018: 26.6%FY 2019: 99.6%FY 2020: -7890.2%FY 2021: -18.8%FY 2022: 76.2%FY 2023: 94.8%FY 2024: 96.3%FY 2025: -16.5%
FY 2016 FY 2025
Free Cash Flow -141.7%
FY 2016: -61.0%FY 2017: 23.5%FY 2018: 54.7%FY 2019: -37.3%FY 2020: -22.7%FY 2021: -17.1%FY 2022: -10.6%FY 2023: 50.9%FY 2024: -150.9%FY 2025: -141.7%
FY 2016 FY 2025

Financial Health

Current Ratio 14.6×
FY 2016: 2.2×FY 2017: 8.0×FY 2018: 8.5×FY 2019: 2.4×FY 2020: 3.2×FY 2021: 3.6×FY 2022: 1.7×FY 2023: 3.3×FY 2024: 20.6×FY 2025: 14.6×
FY 2016 5y median 3.6× FY 2025
Quick Ratio 14.6×
FY 2016: 2.2×FY 2017: 8.0×FY 2018: 8.5×FY 2019: 2.4×FY 2020: 3.2×FY 2021: 3.6×FY 2022: 1.7×FY 2023: 3.3×FY 2024: 20.6×FY 2025: 14.6×
FY 2016 5y median 3.6× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.5×FY 2023: 0.1×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 1.9×
FY 2016: 0.2×FY 2017: 0.2×FY 2018: 1.8×FY 2019: 0.6×FY 2020: 0.6×FY 2021: 0.2×FY 2022: 0.1×FY 2023: 1.2×FY 2024: 5.4×FY 2025: 1.9×
FY 2016 5y median 1.2× FY 2025
Interest Coverage 0.0×
FY 2016: -1.6×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -6065×FY 2021: -34487×FY 2022: -2488×FY 2023: -344×FY 2024: -848×FY 2025: 0.0×
FY 2016 5y median -848× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 413.8%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -107.6%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31